Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Thu Jul 06 17:25:11 UTC 2023
by
admin
on
Thu Jul 06 17:25:11 UTC 2023
|
Protein Sub Type | |
Sequence Origin | HUMAN |
Sequence Type | COMPLETE |
Record UNII |
19GBD6T9L7
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
P14416
Created by
admin on Thu Jul 06 17:25:17 UTC 2023 , Edited by admin on Thu Jul 06 17:25:17 UTC 2023
|
PRIMARY | |||
|
P14416
Created by
admin on Thu Jul 06 17:25:17 UTC 2023 , Edited by admin on Thu Jul 06 17:25:17 UTC 2023
|
PRIMARY | |||
|
19GBD6T9L7
Created by
admin on Thu Jul 06 17:25:17 UTC 2023 , Edited by admin on Thu Jul 06 17:25:17 UTC 2023
|
PRIMARY |
From | To |
---|---|
1_107 | 1_182 |
1_399 | 1_401 |
Glycosylation Type | HUMAN |
Glycosylation Link Type | Site |
---|---|
N | 1_5 |
N | 1_17 |
N | 1_23 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
RADIOLIGAND->TARGET |
|
||
|
AGONIST -> TARGET | |||
|
ANTAGONIST->TARGET |
BINDING
Ki
|
||
|
INHIBITOR -> TARGET |
|
||
|
PARTIAL AGONIST->TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
AGONIST -> TARGET | |||
|
AGONIST -> TARGET |
|
||
|
INHIBITOR -> TARGET |
Ki
|
||
|
PARTIAL AGONIST->TARGET | |||
|
INHIBITOR -> TARGET |
INHIBITOR
Ki
|
||
|
INHIBITOR -> TARGET |
|
||
|
RADIOLIGAND->TARGET |
Ki
|
||
|
INHIBITOR -> TARGET |
ANTAGONIST
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
AGONIST -> TARGET |
|
||
|
LIGAND->TARGET | |||
|
INHIBITOR -> TARGET |
|
||
|
AGONIST -> TARGET | |||
|
INHIBITOR -> TARGET |
Ki
|
||
|
INHIBITOR -> TARGET |
INHIBITOR
Ki
|
||
|
PARTIAL AGONIST->TARGET |
|
||
|
INHIBITOR -> TARGET |
cell:CHO K1; ligand:3H-spiperone
Ki
|
||
|
AGONIST -> TARGET | |||
|
INHIBITOR -> TARGET |
Ki
|
||
|
PARTIAL AGONIST->TARGET | |||
|
PARTIAL AGONIST->TARGET |
Primary target for antipsychotic activity. The partial agonist actions of aripiprazole vary widely depending upon the cellular milieu. Thus, nearly fullagonism, weak partial agonism and frank antagonism, have all been reported, depending upon the assay system and cellular background.
Ki
|
||
|
AGONIST -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
PARTIAL AGONIST->TARGET | |||
|
AGONIST -> TARGET | |||
|
PARTIAL AGONIST->TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
LIGAND->TARGET |
|
||
|
AGONIST -> TARGET |
D2R concentration levels were significantly lower in AD patients than in healthy controls (SMD = −1.13, 95%CI: −1.52 to −0.74), with low heterogeneity (I2 = 7.80%), when USA studies were considered.
|
||
|
INHIBITOR -> TARGET |
|
||
|
AGONIST -> TARGET | |||
|
INHIBITOR -> TARGET |
MAJOR
Ki
|
||
|
AGONIST -> TARGET |
D2S Primary receptor interaction.. Emax 79%
EC50
|
||
|
PARTIAL AGONIST->TARGET |
|
||
|
INHIBITOR -> TARGET |
Binding Assay
IC50
|
||
|
INHIBITOR -> TARGET |
Ki
|
||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET | |||
|
AGONIST -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
AGONIST -> TARGET |
PARTIAL AGONIST
|
||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
|
||
|
PARTIAL AGONIST->TARGET |
Ki
|
||
|
AGONIST -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
PARTIAL AGONIST->TARGET | |||
|
INHIBITOR -> TARGET | |||
|
AGONIST -> TARGET | |||
|
INHIBITOR -> TARGET |
Ki
|
||
|
AGONIST -> TARGET | |||
|
ANTAGONIST->TARGET |
SELECTIVE
|
||
|
INHIBITOR -> TARGET | |||
|
INVERSE AGONIST->TARGET |
Ki
|
||
|
INHIBITOR -> TARGET |
|
||
|
RADIOLIGAND->TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
LIGAND->TARGET |
|
||
|
INHIBITOR -> TARGET | |||
|
AGONIST -> TARGET |
|
||
|
AGONIST -> TARGET | |||
|
PARTIAL AGONIST->TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
ANTAGONIST
|
||
|
AGONIST -> TARGET | |||
|
AGONIST -> TARGET | |||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Molecular Formula | CHEMICAL |
|
||||
MOL_WEIGHT | CHEMICAL |
|